Virginia Powers | Authors


Potential Promise for PD-1 Blockade Seen in Sarcoma Subtypes

February 06, 2017

Several subtypes of difficult-to-treat sarcomas may respond to treatment with PD-1 pathway inhibiting immunotherapies, according to findings of an immunohistochemistry analysis of a large patient population.

Study Findings Show Highly Effective Colorectal Cancer Treatment is Underutilized

February 02, 2017

Patients receiving the same diagnosis, colorectal cancer with synchronous peritoneal metastases (PM), were offered different treatments that led to dramatically different outcomes based upon the institution in which they were diagnosed.

Ribociclib Is Well Tolerated in Elderly Women With HR+/HER2- Breast Cancer

February 02, 2017

A pre-planned subgroup analysis of data from the MONALEESA-2 trial demonstrated similar clinical benefit and safety profiles in elderly patients compared to younger patients with HR+/HER2-advanced breast cancer, supporting a paradigm shift in the future medical management of these patients from the current standard of letrozole to combined treatment of letrozole plus ribociclib.